| NAME | : | Fostamatinib |
| BOBOT | : | 580.4595 |
| RUMUS | : | C23H26FN6O9P |
| THERAPEUTIC INDC | : | Fostamatinib is indicated for use in the treatment of chronic immune thrombocytopenia (ITP) in patients who have had insufficient response to previ... |
| CATEGORIES | : | BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inhibitors / Phosphodiesterase 5 Inhibitors / Tyrosine Kinase Inhibitors / UGT1A1 Inhibitors / Vasodilating Agents |
| STRUCTURE | : |  |